By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Access Pharmaceuticals 

2600 Stemmons Freeway
Suite 176
Dallas  Texas  75207   U.S.A.
Phone: 214-905-5100 Fax: 214-905-5101


SEARCH JOBS



Segment
Pharmaceuticals





Company News
Access Pharmaceuticals (ACCP) Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 9/22/2014 6:59:51 AM
Access Pharmaceuticals (ACCP) Awarded Japan Patent For MuGard And ProctiGard 8/14/2014 8:03:29 AM
Access Pharmaceuticals (ACCP) Announces European License Agreement With Norgine 8/7/2014 7:50:59 AM
Access Pharmaceuticals (ACCP) Featured On OncLive.com 7/30/2014 9:42:02 AM
Access Pharmaceuticals (ACCP) Receives 510(K) FDA Marketing Clearance For ProctiGard™ 7/22/2014 6:57:47 AM
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014 10:32:57 AM
Access Pharmaceuticals (ACCP) MuGard Selected For Cover Article In The Print Edition Of The Journal Cancer 5/1/2014 9:06:28 AM
Access Pharmaceuticals (ACCP) Provides Update On Development Of LexaGard, A Proprietary Formulation Of Amlexanox 4/9/2014 8:29:54 AM
Access Pharmaceuticals (ACCP) Advances Development Of Proctigard™ For Radiation Proctitis 3/21/2014 10:35:15 AM
Access Pharmaceuticals (ACCP) Announces Publication Of MuGard Clinical Data In Cancer Journal 2/18/2014 9:50:04 AM
12345678910...
//-->